【印刷可能】 gelucire 50/13 gattefosse 300229-Gelucire 50/13 gattefosse

Oct 01, 18 · A characterization of solid lipid nanoparticles (SLN) produced starting from an emulsion prepared in acidic or neutral medium and based on Gelucire ® 50/13 as lipid phase was performed by XRay Photoelectron Spectroscopy Analysis (XPS) The smallest particle size and the highest peptide content were observed for GSHSLN produced in acidic medium GSHSLN(HAc)Gelucire® 50/13, Gattefosse) may serve as both solidifying and emulsifying agents for triglycerides The excipient is primarily a mixture of PEG 1500 mono and diesters with palmitic (C 16) and stearic (C 18) acid with an HLB value of ~13 (13) It was used for the development of solid dispersion hydrophobicJun 30, 19 · Gelucire® 50/13;

Vibrational Behavior Of Gelucire 50 13 By Raman And Ir Spectroscopies A Focus On The 1800 1000 Cm 1 Spectral Range According To Temperature And Degree Of Hydration Sciencedirect

Gelucire 50/13 gattefosse

Gelucire 50/13 gattefosse-An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (ie having an HLB value superiorJun 18, 18 · The final product is either a pure PEG ester (Gelucire® 48/16) or a mixture of PEG esters and mono, di and triglycerides (Gelucire® 44/14 and Gelucire® 50/13) The fatty acid repartition depends on the original raw material Gelucire® 48/16 and Gelucire® 50/13 are composed mainly of stearic and palmitic acids, whereas lauric acid is the

Utilizing Pluronic F 127 And Gelucire 50 13 Solid Dispersions For Enhanced Skin Delivery Of Flufenamic Acid Shazly 12 Drug Development Research Wiley Online Library

Jan 01, 17 · The lipid components Gelucire® 50/13 (stearoyl macrogolglycerides, GATTEFOSSÉ GmbH, Bad Krozingen, Germany), Witepsol® S55 (solid triglycerides containing hydrogenated cocoglycerides, beeswax and ceteareth25, CREMER OLEO GmbH & Co KG, Hamburg, Germany), and Capryol® 90 (propylene glycol monocaprylate, Gattefossé GmbH, Bad KrozingenGelucire 44/14 Acylglycerol fraction PEG ester fraction Figure 1 Thermograms of the first melting of Gelucire® 44/14 (solid line), the acylglycerol fraction of Gelucire® 44/14 (dotted line), and the PEG ester fraction of Gelucire® 44/14 (dashed dot dot line) at a heating rate of 3 °C/min 268 OCL VOL 16 N° 4 JUILLETDÉCEMBRE 09Jun 01, 18 · The following are theexamples of hydrophilic grades of gelucire such as 50/13, 44/14, 48/16, 55/18, 35/10, 48/09 Among the above grades, gelucire 50/13 and 44/14 were selected for review as a lot of research works are published using these two grades 12 Gelucire ®

Gelucire 50/13 product page Gattefosse Published 10 Shohin et al, (Journal of Pharmaceutical Sciences Vol 103 pages Published February 14;Application Water dispersible surfactant, Solubilizer, Bioavailability enhancer, Component of SELF, Matrix for modified release, Multiparticulates;Functionality Solubilizer for poorlysoluble APIs and bioavailability enhancer Single excipient formulation system selfemulsifies in aqueous fluid

Provider of personal care ingredients and pharmaceutical excipients, Gattefossé has been exploring the very best of nature and science since 10Gelucire® 50/13 (stearoyl polyoxyl32 glycerides) is a nonionic waterdispersible surfactant for lipidbased formulations to solubilize and increase oral bioavailability of poorly watersoluble APIs Selfemulsifies in aqueous media forming a fine dispersion, ie, microemulsion (SMEDDS)Detailed Specifications for Labrafac™ PG from Gattefossé Product Specs;

Effect Of Different Lipids And Surfactants On Formulation Of Solid Lipid Nanoparticles Incorporating Tamoxifen Citrate Topic Of Research Paper In Nano Technology Download Scholarly Article Pdf And Read For Free On Cyberleninka

Pdf Gelucire 44 14 Based Immediate Release Formulations For Poorly Water Soluble Drugs

Application Oily vehicle, Solubilizer, Bioavailability enhancer, Component of SELF and microemulsions;Other products like Gelucire® 50/13 and 48/16, due to their solidstate characteristics, are suitable for preparation of solid dispersions by melt extrusion or spray atomization for preparation of selfemulsifying solid dosage formsThe aim of this study was to develop a formulation containing fenofibrate and Gelucire(®) 50/13 (Gattefossé, France) in order to improve the oral bioavailability of the drug Particles from gas saturated solutions (PGSS) process was chosen for investigation as a

New Pharmacopoeia Monographs For Gattefosse Speciality Excipients

Utilizing Pluronic F 127 And Gelucire 50 13 Solid Dispersions For Enhanced Skin Delivery Of Flufenamic Acid Shazly 12 Drug Development Research Wiley Online Library

Gelucire 50/13, and Gelucire 43/01 as lipid carriers Ranitidine HCl– lipid granules were prepared by the melt granulation technique and evaluated for in vitro floating and drug release The results revealed that the moderate amount of Gelucire 43/01 and ethyl celluloseGelucire® 44/14, Gelucire® 48/16, Gelucire® 50/13 and the Labrafil® series (Table 2) consist of selfemulsifying excipients that may be in SEDDS / SMEDDS Several of these products listed are liquid or semisolid, hence suitable for soft or hard shell capsules Other products, such as Gelucire® 48/16 and Gelucire® 50/13 areLabrafil® M 1944 CS;

Journal Of Applied Pharmaceutical Science

Lauroyl Polyoxylglycerides Functionalized Coconut Oil Enhancing The Bioavailability Of Poorly Soluble Active Substances Topic Of Research Paper In Chemical Sciences Download Scholarly Article Pdf And Read For Free On Cyberleninka Open

Functionality Oily phase for topical formulations Oily vehicle and solubilizer for solutionsThe aim of this study was to develop a formulation containing fenofibrate and Gelucire(®) 50/13 (Gattefossé, France) in order to improve the oral bioavailability of the drug Particles from gas saturated solutions (PGSS) process was chosen for investigation as a manufacturing process for producing a solid dispersionAbstract, page 267, page ) Elmalehm H el al, Probe into the physical properties of a Gelucire 44/14 pharmaceuitcal formulation Published online 14

Gelucire A Versatile Polymer For Modified Release Drug Delivery System Sciencedirect

Central Composite Designed Ezetimibe Solid Dispersion For Dissolution Enhancement Synthesis And In Vitro Evaluation Therapeutic Delivery

Gelucire® 44/14 Gelucire® 48/16 Gelucire® 50/13 Labrafac™ lipophile WL 1349 Labrafac™ PG Labrafil® M 1944 CS Labrafil® M 2125 CS Labrafil® M 2130 CS Labrasol® ALF Lauroglycol™ 90 Lauroglycol™ FCC Maisine® CCLabrasol®, Gelucire® 44/14, Gelucire® 48/16, Gelucire® 50/13 and the Labrafil® series (Table 2) consist of selfemulsifying excipients that may be in SEDDS / SMEDDS Several of these products listed are liquid or semisolid, hence suitable for soft or hard shell capsulesBetween gelucire 50/13 and poloxamer 1 and to formulate the optimized solid dispersion into immediate release tablets MATERIALS and METHODS Materials Bosentan was received as gift sample from MSN Pharma, India Gelucire 50/13 was received as gift sample from Gattefosse, India, Poloxamer 1 was procured from Sigma Aldrich, India

Woa2 Pharmaceutical Composition Comprising Solid Dispersion Of s Class Ii Drugs With Gelucires Google Patents

Formulating Cannabinoids Pharma Excipients

1234567Next

Incoming Term: gelucire 50/13 gattefosse,